Nitric oxide modulation as a therapeutic strategy in heart failure.

Taylor, Anne L

Taylor, Anne L.

Affiliation

Taylor AL; New York Presbyterian Hospital, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. ataylor@columbia.edu

Heart Fail Clin ; 8(2): 255-72, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22405665

Subject(s)

Heart Failure/blood; Heart Failure/drug therapy; Nitric Oxide/blood; Signal Transduction/drug effects; Biological Availability; Cardiovascular System/drug effects; Endothelium, Vascular/drug effects; Endothelium, Vascular/physiopathology; Guanylate Cyclase/blood; Heart Failure/physiopathology; Humans; Nitric Oxide/physiology; Oxidative Stress/physiology; Phosphodiesterase 5 Inhibitors/pharmacology; Piperazines/pharmacology; Purines/pharmacology; Signal Transduction/physiology; Sildenafil Citrate; Sulfones/pharmacology; Treatment Outcome; Ventricular Dysfunction, Left/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Heart Failure / Nitric Oxide Limits: Humans Language: En Journal: Heart Fail Clin Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google